Abstract:Background and objective. Allergic rhinitis (AR), a highly frequently seen chronic inflammation of the upper respiratory tract, shows a growing global incidence. The modern research on the pro-inflammatory mechanism molecularly offers a new direction for the early therapy AR in the future and also reveals the potential therapeutic targets of IT, which is known as the breakthrough of diagnosis and therapy of AR. Through the screening of GSE43523 data set in GEO, we discovered aberrant expression of granzyme B (GzmB) gene in AR cases. Online data analysis revealed the possible regulation of upstream target microRNA-378a-3p (miR-378a-3p) on its expression. Accordingly, this study analysed the impacts of miR-378a-3p and GzmB on AR to set the foundation for the follow-up associated research and offer novel ideas and directions for the future diagnosis and therapy of AR. Methods. Totally, 24 BALB/c mice were assigned to the AR group, control group, GzmB group, and blank group (each n = 6). The blank group was normally fed without treatment, and the other three groups were treated by ovalbumin (OVA) to induce AR models, in which the GzmB group was intranasally injected with lentiviral vector suppressing GzmB expression during the second immunization, while the control group was given the GzmB-blank vector. The times of AR pathological behaviours such as sneezing and scratching the nose of mice were observed and counted. The nasal lavage fluid of each mouse was acquired, and then, the mouse was executed by cervical dislocation, followed by collection of blood and nasal mucosa tissues. Then, ELISA was adopted for quantifying immunoglobulin E (IgE), interleukin (IL)-4, IL-6, and histamine (HA), and nasal mucosa tissues were treated by HE and TUNEL staining to observing their histopathological manifestations. PCR and western blot (WB) were adopted for quantifying GzmB and miR-378a-3p. Additionally, with NP69 cells, dual luciferase reporter (DLR) assay was carried out for determining the targeting association of GzmB with miR-378a-3p. Another 24 mice were assigned to the AR group, GzmB group, miR-378a-3p group, and GzmB+ miR-378a-3p group (each n = 6). The AR and GzmB groups were treated as above. The miR-378a-3p group was intervened by lentiviral vector suppressing miR-378a-3p, while the GzmB+ miR-378a-3p group was given GzmB and lentiviral vector suppressing miR-378a-3p meantime. A rescue assay was conducted through repeating the above tests. Results. The times of sneezing and rubbing the nose and the levels of IgE, IL-4, IL-6, and HA were similar between the control and AR groups (all P > 0.05 ), and these items of the two groups were all higher than those of the blank and GzmB groups (all P < 0.05 ). However, no notable difference was observed in IL-4 and IL-6 levels between the GzmB and blank groups (both P > 0.05 ), while higher levels of other detection results were found in the former group than in the latter (all P < 0.05 ). The staining results revealed obvious congestion, oedema, and necrosis structures in the nasal mucosa epithelium of the control and AR groups and also revealed a large number of infiltrating eosinophils and notable increase of apoptotic nasal mucosa epithelial cells. The GzmB group showed notably improved nasal mucosa tissues, and its infiltration and apoptosis of eosinophils were more notable than those of the blank group, but notably weaker than those of the AR and control groups. Additionally, the PCR and WB results revealed similar miR-378a-3p and GzmB levels in nasal mucosa between the control and AR groups (both P > 0.05 ), and a notable decrease of miR-378a-3p and a notable increase of GzmB in both groups (both P < 0.05 ). The DLR assay revealed notably suppressed fluorescence activity of GzmB-WT in NP69 cells after transfection of miR-378a-3p mimics ( P < 0.05 ) and notably down regulated GzmB pro -Abstract Truncated-

Changes in Percentage of GATA3+regulatory T Cells and Their Pathogenic Roles in Allergic Rhinitis

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

Notch2-dependent GATA3+Treg cells alleviate allergic rhinitis by suppressing the Th2 cell response

Changes in Circulating CD44+CD62L- Treg Subsets and CD44-CD62L+ Treg Subsets Reflect the Clinical Status of Patients with Allergic Rhinitis

Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis

Nasal Mucosa Remodeling and Expression of Transcription Factors T-bet/GATA-3 in Allergic Rhinitis Mouse Model

Changes in respiratory tract and gut microbiota in AR mice and their relationship with Th1/Th2/Treg

Expression of Peripheral Blood Th17/Treg Cells and Cytokines in Patients with Allergic Rhinitis

[Expression of Peripheral Blood Gammadelta T Cells, Treg Cells and Cytokines IL-17 and TGF-beta1 in Patients with Allergic Rhinitis].

Influences of CD8<SUP>+</SUP> Tregs on Peripheral Blood Mononuclear Cells from Allergic Rhinitis Patients

Peripheral Th17/Treg cell-mediated immunity imbalance in allergic rhinitis patients.

The Expression of IL-27, Th17 Cells and Treg Cells in Peripheral Blood of Patients with Allergic Rhinitis

Correlation of gammadelta-T-cells, Th17 cells and IL-17 in peripheral blood of patients with allergic rhinitis.

Decreased Expression of Foxp3 in Patients with Allergic Rhinitis

Expression of TIM-3 in PBMCs and its relation to Treg in the patients with allergic rhinitis

Polymorphism -509C/T in TGFB1 Promoter Is Associated With Increased Risk and Severity of Persistent Allergic Rhinitis in a Chinese Population.

Study on the Mechanism of Allergic Rhinitis Based on the Expression of FIB, PCT, hs-CRP, and Th17/Treg-IL10/IL-17 Axis Balance

[Content of CD4+ CD25+ Regulatory T Cells in Peripheral Blood Lymphocytes in Patients with Allergic Rhinitis].

Influences of miR-378a-3p on the Pathogenesis of Allergic Rhinitis via GzmB-Mediated Inflammatory Reaction

Expression and Significance of Notch Receptors in the Mouse Model of Allergic Rhinitis